33.43
price down icon0.03%   -0.010
pre-market  プレマーケット:  33.30   -0.13   -0.39%
loading
前日終値:
$33.44
開ける:
$33.6
24時間の取引高:
3.91M
Relative Volume:
0.74
時価総額:
$68.21B
収益:
$39.71B
当期純損益:
$3.17B
株価収益率:
21.73
EPS:
1.5382
ネットキャッシュフロー:
$6.05B
1週間 パフォーマンス:
+1.03%
1か月 パフォーマンス:
-2.34%
6か月 パフォーマンス:
-16.09%
1年 パフォーマンス:
-15.96%
1日の値動き範囲:
Value
$33.25
$33.60
1週間の範囲:
Value
$31.71
$33.60
52週間の値動き範囲:
Value
$31.71
$45.92

Gsk Plc Adr Stock (GSK) Company Profile

Name
名前
Gsk Plc Adr
Name
セクター
Healthcare (1172)
Name
電話
-
Name
住所
-
Name
職員
70,200
Name
Twitter
@GSK
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
GSK's Discussions on Twitter

GSK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
GSK
Gsk Plc Adr
33.43 68.21B 39.71B 3.17B 6.05B 1.5382
Drug Manufacturers - General icon
LLY
Lilly Eli Co
725.72 689.73B 40.86B 8.37B -2.28B 9.25
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
78.69 349.44B 39.36B 13.79B 9.83B 3.086
Drug Manufacturers - General icon
JNJ
Johnson Johnson
147.03 344.63B 87.70B 14.68B 19.03B 6.05
Drug Manufacturers - General icon
ABBV
Abbvie Inc
171.56 303.17B 55.53B 5.12B 15.62B 2.88
Drug Manufacturers - General icon
MRK
Merck Co Inc
97.92 251.88B 63.17B 12.15B 14.84B 4.77

Gsk Plc Adr Stock (GSK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-15 ダウングレード Deutsche Bank Buy → Hold
2024-11-12 ダウングレード Jefferies Buy → Hold
2024-10-31 ダウングレード Guggenheim Buy → Neutral
2024-07-08 ダウングレード UBS Buy → Neutral
2024-05-30 開始されました Goldman Neutral
2024-03-04 アップグレード Guggenheim Neutral → Buy
2024-02-13 アップグレード Citigroup Neutral → Buy
2024-01-23 開始されました Morgan Stanley Equal-Weight
2024-01-16 再開されました UBS Buy
2024-01-03 アップグレード Jefferies Hold → Buy
2023-07-14 開始されました HSBC Securities Reduce
2023-03-17 アップグレード Deutsche Bank Hold → Buy
2023-02-27 再開されました Goldman Buy
2023-01-03 ダウングレード JP Morgan Neutral → Underweight
2022-12-05 ダウングレード BofA Securities Neutral → Underperform
2022-11-11 ダウングレード UBS Neutral → Sell
2022-09-15 アップグレード Credit Suisse Underperform → Neutral
2022-09-08 ダウングレード Jefferies Buy → Hold
2022-08-05 再開されました Morgan Stanley Equal-Weight
2022-07-21 再開されました Citigroup Neutral
2022-02-11 ダウングレード DZ Bank Buy → Hold
2021-11-05 アップグレード Barclays Underweight → Equal Weight
2021-06-24 アップグレード Deutsche Bank Sell → Hold
2021-03-23 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-02-04 ダウングレード Deutsche Bank Hold → Sell
2021-01-20 ダウングレード Credit Suisse Neutral → Underperform
2021-01-15 開始されました Deutsche Bank Hold
2020-11-02 アップグレード Liberum Hold → Buy
2020-09-29 開始されました Berenberg Buy
2020-02-12 ダウングレード Shore Capital Hold → Sell
2020-01-16 ダウングレード Barclays Equal Weight → Underweight
2019-12-02 開始されました SVB Leerink Outperform
2019-11-21 アップグレード UBS Neutral → Buy
2019-10-11 アップグレード Cantor Fitzgerald Hold → Buy
2019-09-03 再開されました Citigroup Neutral
2019-09-03 アップグレード Societe Generale Sell → Buy
2019-08-13 再開されました JP Morgan Neutral
2019-06-17 再開されました Morgan Stanley Underweight
2019-03-08 ダウングレード Shore Capital Buy → Hold
2019-02-22 ダウングレード UBS Buy → Neutral
2019-01-14 ダウングレード Exane BNP Paribas Outperform → Neutral
2018-12-11 再開されました Jefferies Buy
2018-10-09 開始されました Guggenheim Neutral
2018-08-30 ダウングレード Liberum Buy → Hold
2018-04-04 アップグレード Exane BNP Paribas Neutral → Outperform
2018-03-22 アップグレード Morgan Stanley Underweight → Equal-Weight
2018-02-09 アップグレード Kepler Reduce → Hold
すべてを表示

Gsk Plc Adr (GSK) 最新ニュース

pulisher
Jan 17, 2025

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations - Benzinga

Jan 17, 2025
pulisher
Jan 07, 2025

Precidian Investments Builds Out Its ADRhedged ETF Lineup with Four New Strategies, Offering Targeted International Exposure with Integrated Currency Hedge - Business Wire

Jan 07, 2025
pulisher
Dec 23, 2024

Gsk Plc ADR (GSK-N) QuotePress Release - The Globe and Mail

Dec 23, 2024
pulisher
Dec 16, 2024

Best International Companies to Own: 2025 Edition - Morningstar

Dec 16, 2024
pulisher
Dec 12, 2024

FDA Accepts GSK's Filing for Expanded Use of Nucala in COPD - MSN

Dec 12, 2024
pulisher
Dec 11, 2024

GSK Stock Declines 20% In 3 Months: Should You Buy, Sell Or Hold? - Barchart

Dec 11, 2024
pulisher
Dec 11, 2024

GSK Stock Declines 20% in 3 Months: Should You Buy, Sell or Hold? - Zacks Investment Research

Dec 11, 2024
pulisher
Dec 09, 2024

FDA Accepts GSK's Filing For Expanded Use Of Nucala In COPD - Barchart

Dec 09, 2024
pulisher
Dec 06, 2024

GSK Expands Vaccine Collaboration With Zhifei in China - MSN

Dec 06, 2024
pulisher
Dec 02, 2024

GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US - MSN

Dec 02, 2024
pulisher
Dec 02, 2024

The 10 Best US Companies to Invest in Now - Morningstar

Dec 02, 2024
pulisher
Nov 28, 2024

GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine Menveo - Zacks Investment Research

Nov 28, 2024
pulisher
Nov 22, 2024

10 Best Value Stocks to Buy for the Long Term - Morningstar

Nov 22, 2024
pulisher
Nov 18, 2024

5 Stocks to Buy While They’re Still Cheap After Earnings - Morningstar

Nov 18, 2024
pulisher
Nov 13, 2024

Diabetes Care Nutrition Market Report 2024 with Forecasts to 2029 - GlobeNewswire Inc.

Nov 13, 2024
pulisher
Nov 04, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 04, 2024
pulisher
Nov 04, 2024

The Best Defensive Stocks to Buy - Morningstar

Nov 04, 2024
pulisher
Nov 01, 2024

GSK Plc ADR (NYSE: GSK) Has Outstanding Potential - Stocks Register

Nov 01, 2024
pulisher
Oct 30, 2024

GSK Q3 Earnings Top, Stock Down on Lowered '24 View for Vaccine Sales - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

What Do Analysts Think About ICICI Bank Ltd. ADR’s (NYSE:IBN) Future? - Stocks Register

Oct 29, 2024
pulisher
Oct 25, 2024

GSK Plc ADR (GSK): An Important Analyst Insights - Stocks Register

Oct 25, 2024
pulisher
Oct 21, 2024

5 Stocks to Buy if You’re Concerned About US Market Valuations - Morningstar

Oct 21, 2024
pulisher
Oct 18, 2024

21 Best Healthcare Companies to Invest In - Morningstar

Oct 18, 2024
pulisher
Oct 16, 2024

Current share price is - GSK

Oct 16, 2024
pulisher
Oct 15, 2024

D-Wave Quantum Inc (QBTS) rating initates by B. Riley Securities - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

GSK's Studies On Depemokimab For Nasal Polyps Meet Primary Goals - Barchart

Oct 15, 2024
pulisher
Oct 15, 2024

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Oct 15, 2024
pulisher
Oct 15, 2024

GSK Plc ADR [GSK] is 5.59% higher this YTD. Is it still time to buy? - The DBT News

Oct 15, 2024
pulisher
Oct 14, 2024

What You Didn’t Know About General Motors Company (NYSE: GM) This Week - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

GSK’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Before You Invest, Make Sure You Check This ADT Inc (NYSE: ADT) Analysis - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

What Are You Thinking About Investing In Medical Properties Trust Inc (NYSE: MPW) Stock? - Stocks Register

Oct 14, 2024
pulisher
Oct 13, 2024

2 Best Artificial Intelligence Stocks to Buy in October - sharewise

Oct 13, 2024
pulisher
Oct 10, 2024

Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday - sharewise

Oct 10, 2024

Gsk Plc Adr (GSK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$91.84
price up icon 0.21%
drug_manufacturers_general SNY
$50.74
price up icon 0.00%
$272.11
price up icon 0.99%
drug_manufacturers_general PFE
$26.30
price down icon 0.72%
drug_manufacturers_general NVS
$97.53
price down icon 0.34%
drug_manufacturers_general MRK
$97.92
price down icon 2.76%
大文字化:     |  ボリューム (24 時間):